n-acetyl-s-farnesylcysteine has been researched along with Dermatitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fela, DA; Gonzalez, AV; Gordon, JS; Perez, E; Rouzard, K; Sarngadharan, G; Stock, JB; Stock, MB; Wolanin, PM | 1 |
1 other study(ies) available for n-acetyl-s-farnesylcysteine and Dermatitis
Article | Year |
---|---|
Topical N-acetyl-S-farnesyl-L-cysteine inhibits mouse skin inflammation, and unlike dexamethasone, its effects are restricted to the application site.
Topics: Acetylcysteine; Administration, Topical; Animals; Animals, Outbred Strains; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Dermatitis; Dexamethasone; Disease Models, Animal; Ear, External; Edema; Enzyme Inhibitors; Indomethacin; Male; Mice; Mice, Inbred ICR; Neutrophils; Peroxidase | 2008 |